Tokyo - Delayed Quote JPY
PeptiDream Inc. (4587.T)
As of 2:35 PM GMT+9. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
991,537.00
12,420,969.00
-82,929.00
6,654,708.00
1,732,733.00
Investing Cash Flow
12,056,452.00
1,302,539.00
-27,377,217.00
-2,283,450.00
-1,200,025.00
Financing Cash Flow
1,080,980.00
264,191.00
20,789,451.00
66,067.00
-237,244.00
End Cash Position
25,317,558.00
19,507,861.00
5,247,665.00
11,746,529.00
7,149,358.00
Capital Expenditure
-1,772,742.00
-1,368,962.00
-3,975,416.00
-1,214,678.00
-586,260.00
Issuance of Capital Stock
--
--
--
44,940.00
6,569.00
Issuance of Debt
--
4,000,000.00
22,400,000.00
--
--
Repayment of Debt
-2,540,000.00
-2,340,000.00
-1,680,000.00
--
--
Repurchase of Capital Stock
-143.00
-514,554.00
-167.00
-362.00
-243,813.00
Free Cash Flow
-781,205.00
11,052,007.00
-4,058,345.00
5,440,030.00
1,146,473.00
12/31/2020 - 6/12/2013
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
4565.T Nxera Pharma Co., Ltd.
1,188.00
-1.00%
VICO.ST Vicore Pharma Holding AB (publ)
7.95
-0.63%
BINV.ST BioInvent International AB (publ)
45.00
-1.10%
BSLN.SW Basilea Pharmaceutica AG
42.60
-1.16%
TLPPF Telix Pharmaceuticals Limited
14.45
0.00%
DSGN Design Therapeutics, Inc.
5.94
+6.83%
PHVS Pharvaris N.V.
25.01
+7.76%
CGEM Cullinan Therapeutics, Inc.
16.48
+3.13%
SANN.SW Santhera Pharmaceuticals Holding AG
8.69
-1.70%
OCS Oculis Holding AG
16.89
-3.82%